• miR-519d Targets Rab10 to Induce Autophagy and Apoptosis in

  2026-06-22

  This study demonstrates that overexpression of microRNA-519d suppresses proliferation and induces both autophagy and apoptosis in hepatocellular carcinoma (HCC) cells by targeting Rab10 and activating AMPK signaling. The findings clarify a novel regulatory axis in HCC, offering molecular insight for potential therapeutic strategies.

• Octenidine Dihydrochloride: Mechanisms, Innovations, and Res

  2026-06-22

  Explore the science of Octenidine dihydrochloride as an antiseptic research compound. This article reveals its molecular mechanism, practical assay insights, and novel innovations in broad-spectrum antimicrobial research.

• Latrunculin A: Precision Reversible Inhibitor for Actin Asse

  2026-06-21

  Latrunculin A, a reversible inhibitor of actin assembly, empowers researchers to dissect cytoskeleton dynamics, cell morphology, and viral pathogenesis with unmatched temporal control. This guide details experimental workflows, troubleshooting insights, and new translational applications, building on recent proteomic breakthroughs.

• α2-AR Agonists: Advancing Immune Modulation in Osteosarcoma

  2026-06-20

  A strategic overview for translational researchers on leveraging selective α2-adrenergic receptor agonists, such as 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine, to tackle immune rejection and recurrence in post-surgical osteosarcoma. Grounded in recent mechanistic insights and translational studies, the article offers practical guidance on experimental design, product selection, and future clinical directions.

• Alternariol in Mycotoxin Research: Protocols & Advanced Appl

  2026-06-19

  Alternariol (AOH) is transforming mycotoxin research, enabling detailed mechanistic studies of hepatotoxicity and apoptosis. Leveraging new omics-driven insights and optimized protocols, researchers can now probe cytochrome P450 metabolism, liver fibrosis pathways, and mycotoxin detoxification strategies with unprecedented precision.

• DeferoxamineB: Optimizing Iron Chelation in Cancer Research

  2026-06-19

  Harness the full experimental power of Deferoxamine (DeferoxamineB) as an iron chelator, apoptosis inducer, and autophagy modulator in cancer research. Discover advanced protocols, troubleshooting, and insights into metabolic intervention strategies that make this APExBIO compound a cornerstone for regulated cell death studies.

• Triacetin (Glyceryl Triacetate): Applied Protocols in Metabo

  2026-06-18

  Triacetin stands out as a versatile lipid-related biochemical reagent for metabolic, oncology, and ocular research. This article breaks down evidence-driven workflows, troubleshooting tips, and the novel insights that make APExBIO’s Triacetin a preferred choice for reproducible, advanced life science experimentation.

• Selective Senescent Cell Removal in Chondrocyte Expansion Us

  2026-06-18

  This study demonstrates that the senolytic peptide FOXO4-DRI selectively eliminates senescent cells from extensively cultured human chondrocytes, which are critical for autologous chondrocyte implantation (ACI). Although removal of these cells reduces the senescence-associated secretory phenotype, it does not directly enhance the chondrogenic potential, highlighting both promise and the complexity of senescence-targeted strategies in tissue engineering.

• Propranolol Modulates Metabolic Pathways After Severe Burn I

  2026-06-17

  This phase II randomized controlled trial reveals that propranolol, a nonselective beta-blocker, profoundly alters metabolomic and lipidomic profiles in severe burn patients. By normalizing key metabolic and inflammatory pathways in adipose tissue, propranolol attenuates hypermetabolic stress responses, offering mechanistic insight into its clinical benefits.

• MTT: Precision in In Vitro Cell Proliferation and Viability

  2026-06-17

  MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) enables robust, quantitative colorimetric analysis of cell proliferation and metabolic activity. APExBIO's high-purity MTT streamlines workflows and delivers reproducible results in advanced biomedical research, as evidenced in recent ovarian cancer studies.

• AhR Antagonism Mitigates MEHP-Induced Ovarian Toxicity in Mi

  2026-06-16

  This study demonstrates that the aryl hydrocarbon receptor (AhR) mediates the toxic effects of the phthalate metabolite MEHP on mouse ovarian antral follicles. Using the AhR antagonist CH 223191, researchers showed partial rescue of follicle growth and estrogen signaling, implicating AhR as a central pathway in phthalate-induced reproductive toxicity.

• EPZ5676: Next-Generation DOT1L Inhibitor for Immunoepigeneti

  2026-06-16

  Explore the advanced mechanism and immunomodulatory impact of EPZ5676, a potent DOT1L inhibitor, in epigenetic and leukemia research. This article reveals unique insights from recent studies and practical assay guidance.

• Applied Workflows with G-1, a Selective GPR30 Agonist

  2026-06-15

  G-1 (CAS 881639-98-1) empowers researchers to selectively activate GPR30 in models spanning oncology, cardiovascular, and neuropathic pain research, delivering reliable, high-sensitivity readouts. This article distills bench-proven protocols, troubleshooting strategies, and recent mechanistic insights for maximizing the impact of G-1 in advanced experimental settings.

• Mechanisms of WDR19 Hypomorphic Variant in Kidney Failure

  2026-06-15

  This study dissects the pathogenic mechanisms of a hypomorphic WDR19 variant, prevalent in the Arab Druze population, as a leading cause of adult-onset nonsyndromic chronic kidney disease. By leveraging patient-specific stem cell models and kidney organoids, the research uncovers cilia-mediated disruptions in nephron development and key pathway dysregulations, offering new insights for ciliopathy research.

• Octenidine Dihydrochloride: Advanced Workflows in Antiseptic

  2026-06-14

  Octenidine dihydrochloride empowers researchers with robust antimicrobial workflows through targeted microbial membrane disruption. This guide translates the latest evidence and innovations into actionable protocols, troubleshooting insights, and advanced applications—anchored by APExBIO's high-purity formulation.

16306 records 1/1088 page Next 12345 下5页 Last page